Evidence map›Paper›PMID 37745438›Full record

ArticlebioRxiv : the preprint server for biology2024

Developmental pyrethroid exposure disrupts molecular pathways for MAP kinase and circadian rhythms in mouse brain.

Jennifer H Nguyen, Melissa A Curtis, Ali S Imami, William G Ryan, Khaled Alganem, Kari L Neifer, Nilanjana Saferin, Charlotte N Nawor, Brian P Kistler, Gary W Miller and 3 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 8 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Jennifer H NguyenDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614.ORCID 0009-0008-8708-0117
Melissa A CurtisDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614.
Ali S ImamiDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614.ORCID 0000-0003-3684-3539
William G RyanDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614.ORCID 0000-0003-4868-4002
Khaled AlganemDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614.ORCID 0000-0002-7368-5763
Kari L NeiferDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614.ORCID 0000-0002-3691-3851
Nilanjana SaferinDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614.ORCID 0000-0001-5584-1032
Charlotte N NaworDepartment of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614.
Brian P KistlerDepartment of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614.
Gary W MillerDepartment of Environmental Health, Emory Rollins School of Public Health, Atlanta, GA 30322.ORCID 0000-0001-8984-1284
Rammohan ShuklaDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614.ORCID 0000-0001-5776-2506
Robert E McCullumsmithDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614.ORCID 0000-0001-6921-7150
James P BurkettDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614.ORCID 0000-0002-6357-5499
University of Toledo · USColumbia University · USNeurosciences Institute · USUniversity of Wyoming · US

Funding

Vesicular Modulation of Dopamine Neuron ToxicityR01ES023839 · NIEHS · EMORY UNIVERSITY · PI MILLER, GARY W · 2015 to 2025
$5.0M
Translational assessment of brain bioenergetic function in schizophreniaR01MH121102 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI MARANO, CHRISTOPHER, MCCULLUMSMITH, ROBERT E · 2020 to 2024
$3.7M
Cross platform analysis of drug targets and toxicity of bath saltsU01DA054330 · NIDA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI Isaac T Schiefer · 2022 to 2026
$3.0M
Cell-specific analysis of sub-kinomes in schizophreniaR01MH107487 · NIMH · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI MCCULLUMSMITH, ROBERT E, MELLER, JAREK · 2016 to 2020
$1.9M
Training in Molecular and translational Cell DynamicsT32GM144873 · NIGMS · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI AVIDOR-REISS, TOMER, DWORKIN, LANCE DOUGLAS · 2022 to 2024
$1.3M
Behavioral and Neurological Effects of Developmental Pyrethroid Exposure in RodentsR00ES027869 · NIEHS · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI BURKETT, JAMES · 2020 to 2022
$747k
NIDA NIH HHS U01 DA054330NIEHS NIH HHS R00 ES027869NIEHS NIH HHS R01 ES023839NIGMS NIH HHS T32 GM144873NIMH NIH HHS R01 MH107487NIMH NIH HHS R01 MH121102
6 · The paper itself

Abstract

Neurodevelopmental disorders (NDDs) are a category of pervasive disorders of the developing nervous system with few or no recognized biomarkers. A significant portion of the risk for NDDs, including attention deficit hyperactivity disorder (ADHD), is contributed by the environment, and exposure to pyrethroid pesticides during pregnancy has been identified as a potential risk factor for NDD in the unborn child. We recently showed that low-dose developmental exposure to the pyrethroid pesticide deltamethrin in mice causes male-biased changes to ADHD- and NDD-relevant behaviors as well as the striatal dopamine system. Here, we used an integrated multiomics approach to determine the broadest possible set of biological changes in the mouse brain caused by developmental pyrethroid exposure (DPE). Using a litter-based, split-sample design, we exposed mouse dams during pregnancy and lactation to deltamethrin (3 mg/kg or vehicle every 3 days) at a concentration well below the EPA-determined benchmark dose used for regulatory guidance. We raised male offspring to adulthood, euthanized them, and pulverized and divided whole brain samples for split-sample transcriptomics, kinomics and multiomics integration. Transcriptome analysis revealed alterations to multiple canonical clock genes, and kinome analysis revealed changes in the activity of multiple kinases involved in synaptic plasticity, including the mitogen-activated protein (MAP) kinase ERK. Multiomics integration revealed a dysregulated protein-protein interaction network containing primary clusters for MAP kinase cascades, regulation of apoptosis, and synaptic function. These results demonstrate that DPE causes a multi-modal biophenotype in the brain relevant to ADHD and identifies new potential mechanisms of action.

Indexed as

circadian rhythmsdevelopmental disorderskinomicsMAP kinasemultiomics integrationtranscriptomics

Identifiers

PMID37745438
PMCPMC10515776
OpenAlexW4386243504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.